Implantable Medical Devices Global Market Report 2025

The implantable medical devices market size has grown strongly in recent years. It will grow from $103.16 billion in 2024 to $109.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an aging population, increased demand for minimally invasive surgeries, the expansion of healthcare infrastructure in developing countries, and higher healthcare spending.

The implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $140.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth anticipated during the forecast period can be attributed to the increasing incidence of lifestyle-related disorders, rising demand for personalized treatments, the expansion of outpatient surgical procedures, and the growing adoption of bio-compatible materials. Key trends expected in the forecast period include technological advancements in implantable devices, ongoing research and development in bioengineered implants, the emergence of smart and connected implants, innovations in miniaturized electronics for implants, and a heightened focus on 3D printing and custom implant design.

The growing demand for minimally invasive surgical procedures is expected to drive the expansion of the implantable medical devices market in the coming years. Minimally invasive procedures are medical interventions conducted through small incisions or openings, which help minimize patient trauma and recovery time. This demand is rising due to the benefits such procedures offer, including quicker recovery, lower risk of complications, reduced pain, and smaller scars, making them more attractive to patients seeking safer and faster treatment options. Implantable medical devices play a crucial role in these procedures by facilitating targeted therapy delivery and real-time monitoring. They contribute to faster healing, decreased complication risks, and improved long-term outcomes through precise and personalized interventions. For example, in November 2024, the American Society of Plastic Surgeons, a U.S.-based non-profit organization, reported that the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, reflecting a 7% rise from 23,672,269 in 2022. Thus, the increasing demand for minimally invasive surgical procedures is fueling the growth of the implantable medical devices market.

Leading companies in the implantable medical devices market are prioritizing the development of advanced technologies and obtaining regulatory approvals, such as those in the field of bioelectric medicine, to improve treatment effectiveness, minimize side effects, and deliver personalized, minimally invasive therapeutic options. Bioelectric medicine involves the use of electrical signals to diagnose, treat, or stimulate the nervous system to enhance health and manage various conditions. For example, in July 2023, Boston Scientific Corporation, a biotechnology company based in the U.S., received approval from the U.S. Food and Drug Administration (FDA) for its Vercise Neural Navigator 5 Software. When used in conjunction with the Vercise Genus deep brain stimulation (DBS) systems, this software offers clinicians straightforward and actionable data for efficient programming in the treatment of patients with Parkinson’s disease or essential tremor. It allows for more flexible programming, enabling customized treatment plans tailored to each patient’s specific symptoms and requirements.

In November 2024, Boston Scientific Corporation, a medical device company based in the U.S., acquired Axonics Inc. for approximately $3.7 billion. Through this acquisition, Boston Scientific seeks to strengthen its urology and pelvic health portfolio by incorporating Axonics’ advanced sacral neuromodulation systems and Bulkamid urethral bulking agent, thereby providing improved treatment options for patients suffering from urinary and bowel dysfunction. Axonics Inc. is a U.S.-based medical technology firm specializing in implantable devices designed to treat urinary and bowel disorders.

Major players in the implantable medical devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Henry Schein Inc., Alcon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Terumo Medical Corporation, Smith & Nephew plc, W. L. Gore & Associates Inc., Edwards Lifesciences Corporation, Dentsply Sirona Inc., Demant A/S, Institut Straumann AG, Biotronik SE & Co. KG, Integra LifeSciences Holdings Corporation, Conmed Corporation, Globus Medical Inc., LivaNova Public Limited Company, MicroPort Scientific Corporation, B. Braun Melsungen Aktiengesellschaft.

North America was the largest region in the implantable medical devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable medical devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Implantable medical devices are instruments or apparatuses surgically inserted into the human body to monitor, support, or replace a biological function. These devices are intended to stay inside the body for extended durations, either temporarily or permanently, to assist in diagnosing, treating, or managing various medical conditions.

The primary types of implantable medical devices include cardiovascular implants, orthopedic implants, ophthalmology implants, dental implants, cochlear implants, microchip implants, and others. Cardiovascular implants are devices surgically placed to support, repair, or replace parts of the heart or blood vessels, such as stents, pacemakers, or artificial valves. These implants can be made from various biomaterials including ceramics, metals, polymers, and natural substances, and are used by end users like hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and more.

The implantable medical devices market research report is one of a series of new reports that provides implantable medical devices market statistics, including the implantable medical devices industry global market size, regional shares, competitors with the implantable medical devices market share, detailed implantable medical devices market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable medical devices industry. These implantable medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable medical devices market consists of sales of diagnostic implants, therapeutic implants, monitoring implants, and mechanical implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.